160 related articles for article (PubMed ID: 300062)
1. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.
Vosmík J; Jedlicka K; Mulder JL; Cort JH
Gastroenterology; 1977 Apr; 72(4 Pt 1):605-9. PubMed ID: 300062
[TBL] [Abstract][Full Text] [Related]
2. Effect of vasopressin on portal venous pressure.
Kallio H; Lempinen M
Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347
[TBL] [Abstract][Full Text] [Related]
3. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage.
Tsai YT; Lee FY; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lay CS; Lai KH; Lo KJ
Hepatology; 1991 Mar; 13(3):407-12. PubMed ID: 1999311
[TBL] [Abstract][Full Text] [Related]
4. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
García-Compeán D; Blanc P; Bories JM; Michel J; Desprez D; Pageaux GP; David XR; Larrey D; Michel H
Arch Med Res; 1997; 28(2):241-5. PubMed ID: 9204616
[TBL] [Abstract][Full Text] [Related]
5. Living-related liver transplantation in patients with variceal bleeding: outcome and prognostic factors.
Hedaya MS; El Moghazy WM; Uemoto S
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):358-62. PubMed ID: 19666403
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic hemodynamics in cirrhotic patients with esophageal varices and gastrointestinal bleeding.
Lebrec D; Kotelanski B; Cohn JN
Gastroenterology; 1976 Jun; 70(6):1108-11. PubMed ID: 1083820
[TBL] [Abstract][Full Text] [Related]
7. Effects of vasopressin on left gastric venous flow in cirrhotic patients with esophageal varices.
Ohnishi K; Sato S
Am J Gastroenterol; 1990 Mar; 85(3):293-5. PubMed ID: 2178400
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
Walker S; Kreichgauer HP; Bode JC
Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
10. The hemodynamic effects of triglycyl-lysine-vasopressin (Glypressin) in patients with parkinsonism and orthostatic hypotension.
Rittig S; Arentsen J; Sørensen K; Matthiesen T; Dupont E
Mov Disord; 1991; 6(1):21-8. PubMed ID: 2005918
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
Badruddin AH; Rasool G; Chaudhry MA
J Coll Physicians Surg Pak; 2006 Dec; 16(12):755-9. PubMed ID: 17125633
[TBL] [Abstract][Full Text] [Related]
12. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
13. [Prediction of bleeding risks and death in cirrhosis based on hemodynamic and metabolic variables. A study of patients with esophageal varices without previous bleeding].
Møller S; Bendtsen F; Christensen E; Henriksen JH
Ugeskr Laeger; 1995 Sep; 157(39):5389-93. PubMed ID: 7483052
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
Silvain C; Carpentier S; Sautereau D; Czernichow B; Métreau JM; Fort E; Ingrand P; Boyer J; Pillegand B; Doffël M
Hepatology; 1993 Jul; 18(1):61-5. PubMed ID: 8325622
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
16. Hepatic venous pressure gradient and outcomes in cirrhosis.
Ripoll C
J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.
Merkel C; Bolognesi M; Angeli P; Noventa F; Caregaro L; Sacerdoti D; Gatta A
Am J Gastroenterol; 1989 Jul; 84(7):717-22. PubMed ID: 2787099
[TBL] [Abstract][Full Text] [Related]
18. [The long-term effect of molsidomine on frequency of hemorrhage, portal and cardiac hemodynamics in patients with liver cirrhosis--a pilot study].
Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
Leber Magen Darm; 1993 May; 23(3):114-8, 121-2. PubMed ID: 8326815
[TBL] [Abstract][Full Text] [Related]
19. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.
Orloff MJ; Orloff MS; Orloff SL; Rambotti M; Girard B
J Am Coll Surg; 1995 Mar; 180(3):257-72. PubMed ID: 7874335
[TBL] [Abstract][Full Text] [Related]
20. [Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
Fort E
Gastroenterol Clin Biol; 1990; 14(11):898-9. PubMed ID: 2276578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
